0TN Stock Overview
A medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Bioretec Oy Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.84 |
| 52 Week High | €2.94 |
| 52 Week Low | €1.69 |
| Beta | 0 |
| 11 Month Change | -5.90% |
| 3 Month Change | -33.03% |
| 1 Year Change | -15.83% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -30.75% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0TN | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -7.8% | -1.0% | -0.02% |
| 1Y | -15.8% | -7.3% | 8.2% |
Return vs Industry: 0TN underperformed the German Medical Equipment industry which returned -7.3% over the past year.
Return vs Market: 0TN underperformed the German Market which returned 8.2% over the past year.
Price Volatility
| 0TN volatility | |
|---|---|
| 0TN Average Weekly Movement | 7.2% |
| Medical Equipment Industry Average Movement | 5.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: 0TN's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 0TN's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | n/a | Alan Donze | bioretec.com |
Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; ActivaPin, a bioabsorbable implant for upper and lower limb fractures; and ActivaScrew, an absorbable surgical implant that is used in fracture treatment, osteotomy, arthrodesis, and bone graft surgery. It also provides ActivaScrew Cannulated that offers a range of fully threaded and partially threaded cannulated screws for fixation of fractures and osteotomies; ActivaScrew Interference, a tool for multiple uses regarding bone fractures, osteotomies, arthrodesesm, and bone grafts; ActivaScrew Interference TCP, a biocomposite interference screw; and RemeOs Screw, a magnesium screw implants.
Bioretec Oy Fundamentals Summary
| 0TN fundamental statistics | |
|---|---|
| Market cap | €37.83m |
| Earnings (TTM) | €0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 0TN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0TN income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | €0 |
| Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 0TN perform over the long term?
See historical performance and comparison